Skip to content
GDPR-compliant data management
ISO-certified laboratory
Hospital laboratory quality
Discreet ordering & shipping
Therapy based on the latest science
Cart
More energy
Mental clarity
More muscle power
Performance
weight loss
Higher quality of life
Better sleep
Wellbeing

Book your initial consultation here.

Adon Health

What you can expect from a well-adjusted therapy

90% of men report noticeable improvements in general well-being, energy levels, and performance after just three months.

Read customer reviews *Every change is individual: That's why your therapy will be supervised by doctors experienced in TRT.
Adon Health

Medical care you can trust

Every TRT at Adon Health is supervised by experienced, independent doctors – according to clear medical guidelines and with maximum data security.

  • Personal care provided by independent cooperating physicians
  • Regular blood tests & dosage monitoring
  • Medical support according to current guidelines
  • Detailed information about effects and side effects
  • GDPR-compliant data protection of your health data

Individual treatment methods are used, tailored to your individual situation.

All treatment methods are scientifically sound, clinically proven, and regularly monitored by doctors.
Your treating physician will decide which form is medically appropriate for you after careful consideration.

EVERY 1-2 WEEKS

Testosterone enanthate

The medication is injected regularly as recommended by a doctor in order to achieve a stable hormone level.

DAILY

Testosterone gel

The gel is applied to the skin once a day - usually to the shoulders or upper arms.

Do you have any questions?

Here is an overview of the most frequently asked questions and answers.

Everyone sees

Sources:

Thomas G. Travison, Andre B. Araujo, Amy B. O'Donnell, Varant Kupelian, John B. McKinlay, A population-level decline in serum testosterone levels in American men. The Journal of Clinical Endocrinology & Metabolism , Volume 92, Issue 1, January 2007, Pages 196–202. https://doi.org/10.1210/jc.2006-1375

Mulligan, T., Frick, M., Zuraw, Q., Stemhagen, A., & McWhirter, C. (2008a). Prevalence of hypogonadism in males aged at least 45 years: the HIM study. International Journal of Clinical Practice , 60 (7), 762–769. https://doi.org/10.1111/j.1742-1241.2006.00992.x

Stanworth, R., & Jones, T.H. (2008). Testosterone for the aging male; current evidence and recommended practice. Clinical Interventions in Aging , Volume 3 , 25–44. https://doi.org/10.2147/cia.s190

Peterson, MD, Belakovskiy, A., McGrath, R., & Yarrow, JF (2018). Testosterone deficiency, weakness, and multimorbidity in men. Scientific Reports , 8 (1). https://doi.org/10.1038/s41598-018-24347-6

Saad, F., Aversa, A., Isidori, AM, Zafalon, L., Zitzmann, M., & Gooren, L. (2011). Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology , 165 (5), 675–685. https://doi.org/10.1530/eje-11-0221